CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
Chimaera Long Naildevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06285981
NCT06285981N/ACompleted

Observational Retrospective Study to Assess the Clinical Benefit and Safety Profile of the Intramedullary Nail CHIMAERA in Adult Patient Who Have Suffered Pertrochanteric, Intertrochanteric and Subtrochanteric Fractures of the Femur in Daily Practice: CHIMAERA Study

Orthofix s.r.l.·observational·Posted Feb 29, 2024·Updated Sep 15, 2025

In Brief

An observational study evaluating Chimaera Long Nail for Pertrochanteric Fracture of Femur and 2 related conditions. Completed, enrolled 44 participants across 2 sites.

Detailed Summary

The CHIMERA study intends to evaluate the clinical benefits of the study medical device in the standard clinical practice.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 29, 2024
Enrollment StartNov 27, 2023
Primary CompletionDec 17, 2024
Study CompletionDec 18, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.3 years ago

Interventions

Chimaera Long Naildevice

The CHIMAERATM, is an internal fixation system intended intended for insertion into the medullary canal of a femur in individuals suffering from stable and unstable pertrochanteric, intertrochanteric and subtrochanteric fractures of the femur alone or when these fractures occur in combination with shaft fractures extending distally to a point approximately 10cm proximal to the intercondylar notch.